Skip to search formSkip to main contentSkip to account menu

Hexalen

Known as: MGI Pharma Brand of Altretamine 
National Institutes of Health

Related topics

Related topics

29 relations

Broader (4)

Alkylating AgentsAltretamineAntineoplastic Agents, AlkylatingChemosterilants
Altretamine 50 MG Oral Capsule [Hexalen]Altretamine/cisplatin/cyclophosphamide/doxorubicin protocolHAC protocolHMiVe protocol

Narrower (4)

CisplatinHFAP protocolHexAFpentamethylmelamine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Preliminary thermoluminescence investigation of commercial pharmaceutical glass containers towards the sterilization dosimetry of liquid drugs.
2007
2007
Un cas de syndrome myélodysplasique traité avec de la décitabine
Resume Objectif : Presentation d’un cas de syndrome myelodysplasique traite a l’aide de la decitabine. Resume du cas : Il s’agit… 
Review
2006
Review
2006
Drug development in anaesthesia: industrial perspective
Purpose of review In this review, we summarize the new drugs in development in the anaesthesia field. Recent findings There are… 
2005
2005
Prosthodontic management of patients with xerostomia
2004
2004
Cytoplasmic components of apoptosis by irofulven revealed by cell-free apoptotic systems
5185 The potent induction of apoptosis in various types of tumor cells, contrasted to largely reversible non-apoptotic effects in… 
2004
2004
Updated antiemesis guidelines include new approvals
The National Comprehensive Cancer Network (NCCN) Antiemesis panel recently updated its guidelines for the prevention of CINV to… 
2000
2000
[Combination chemotherapy with hexamethylamine (Hexalen, Altretamine, Hexastat) and sarcolysine in advanced ovarian carcinoma].
Combination chemotherapy with hexamethylmelamine (hexalen, altretamine, hexastat), 100 mg, thrice a day, per os, 14 days (out of… 
1995
1995
513 Trial of oral hexalen for relapsed ovarian carcinoma [OV/CA]: Comparison of CA125 and EORTC response definitions
1994
1994
MGI Pharma hopes Salagen makes it profitable
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)